Chai Discovery Announces Collaboration with Novartis to Advance AI-Driven Antibody Discovery - BioSpace

A pharmaceutical company is partnering with an AI firm to develop new antibodies for medicines more efficiently. This could eventually lead to better or faster drug development, benefiting patients.